Clinical Trial Update: Efficacy and Safety of Apremilast in Combination with NBUVB and NBUVB Alone in Vitiligo Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating apremilast in combination with narrowband UV-B phototherapy versus UV-B alone for vitiligo, focusing on efficacy and safety; e…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vitiligo

Drugs mentioned

• Apremilast (apremilast)

Snippet

Sponsor: Dow University of Health Sciences | Conditions: Vitiligo | Phase 4 | Status: ENROLLING_BY_INVITATION